Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesOvation Science Inc

Ovation Science Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.02 CAD 0.00(0%)
Last update at 2026-11-06T14:30:00Z
Market Cap
1.34M

Momentum Score

…

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness solutions under the Invibe MD name; anti-aging products and skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.02
Low
0.02
High
52 Week Price Range
0.03
Low
0.06
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ovation Science Inc is a Canadian-listed company (OVAT.CN) for which public disclosures are limited and its core operations and products are not clearly described in available filings. Major long-term growth drivers are therefore unclear; investors may find potential upside if management clarifies strategy, achieves commercialization milestones or secures sustainable funding and partnerships.

Material risks include limited public disclosure, low trading liquidity, early-stage or unproven operations and the potential need for additional financing to support execution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
0.06M
Revenue Per Share
0.00
Gross Profit TTM
0.05M
Debt / Equity
-
ROE
-602.13%
Net Debt
0.27M
ROCE
43.93%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.46M -0.81M -0.79M -2.39M -1.18M
Net income -0.46M -0.81M -0.79M -2.39M -1.18M
Selling general administrative 0.25M 0.47M 0.45M 0.43M 1.47M
Gross profit 0.09M 0.05M 0.14M 0.19M 0.52M
Reconciled depreciation 0.00M 0.00M 0.01M 0.01M 0.01M
Ebit - - - - -0.94M
Ebitda - - -0.79M -2.39M -1.16M
Operating income -0.48M -0.70M -0.79M -0.83M -1.09M
Interest expense 0.05M 0.03M 0.00M 0.00M 0.02M
Interest income - 0.00M 0.00M 0.00M 0.01M
Net interest income -0.05M -0.03M -0.00M 0.00M -0.00M
Total revenue 0.11M 0.06M 0.14M 0.22M 0.75M
Total operating expenses 0.59M 0.76M 0.93M 1.05M 1.84M
Cost of revenue 0.03M 0.01M 0.00M 0.04M 0.23M
Total other income expense net 0.07M -0.09M -0.00M -1.57M -0.09M
Net income from continuing ops -0.46M -0.81M -0.79M -2.39M -1.18M
Net income applicable to common shares - - - - -1.18M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.06M 0.08M 0.10M 0.77M 3.25M
Intangible assets - - - - 0.74M
Total liab 1.15M 0.73M 0.19M 0.06M 0.14M
Total stockholder equity -1.09M -0.65M -0.08M 0.71M 3.11M
Other current liab 0.02M 0.06M - - -
Common stock - - - - 4.28M
Capital stock 4.52M 4.46M 4.28M 4.28M 4.28M
Retained earnings -7.05M -6.59M -5.78M -4.98M -2.59M
Cash 0.00M 0.05M 0.03M 0.65M 0.38M
Total current liabilities 1.15M 0.71M 0.17M 0.06M 0.14M
Net debt 0.27M 0.14M 0.01M - -
Short long term debt 0.27M 0.17M 0.02M - -
Other stockholder equity - - - - 1.42M
Property plant equipment - - - - 0.02M
Total current assets 0.06M 0.07M 0.10M 0.76M 2.49M
Net tangible assets - - - - 2.37M
Short term investments - - - 0.00M 1.16M
Net receivables 0.03M 0.00M 0.05M 0.08M 0.05M
Long term debt - 0.02M 0.02M - -
Inventory 0.03M 0.02M 0.00M 0.00M 0.89M
Accounts payable 0.13M 0.06M 0.02M 0.02M 0.10M
Non current assets total 0.00M 0.00M 0.01M 0.01M 0.76M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - 0.00M 1.16M -0.55M
Change to liabilities - - - - 0.06M
Total cashflows from investing activities - - - - -0.69M
Net borrowings 0.07M 0.17M 0.03M 0.00M -0.10M
Total cash from financing activities 0.13M 0.36M 0.05M 0.00M 2.05M
Change to operating activities - - - - 0.04M
Net income -0.46M -0.81M -0.79M -2.39M -1.18M
Change in cash -0.05M 0.02M -0.62M 0.27M 0.00M
Begin period cash flow 0.05M 0.03M 0.65M 0.38M 0.38M
End period cash flow 0.00M 0.05M 0.03M 0.65M 0.38M
Total cash from operating activities -0.18M -0.34M -0.67M -0.89M -1.39M
Issuance of capital stock 0.07M 0.20M 0.02M 0.00M 1.97M
Depreciation 0.00M 0.00M 0.01M 0.01M 0.01M
Change to inventory -0.01M -0.03M 0.00M 0.04M -0.78M
Change to account receivables - - - - 0.01M
Other cashflows from financing activities - - - - -0.15M
Change to netincome - - - - 0.46M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.14M
Change in working capital 0.32M 0.32M 0.12M -0.08M -0.67M
Stock based compensation 0.00M 0.04M 0.00M 0.00M 0.41M
Other non cash items 0.02M 0.03M 0.00M - 0.00M
Free cash flow -0.18M -0.34M -0.67M -0.89M -1.52M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OVAT
Ovation Science Inc		 -
-%		 0.02 - - 21.07 6.71 25.35 -0.18
GTII
Green Thumb Industries Inc		 -0.23
2.41%		 9.30 14.70 34.84 1.91 0.86 1.61 3.95
CL
Cresco Labs Inc		 -
-%		 0.79 - 105.26 0.70 0.99 1.32 42.44
JUSH
Jushi Holdings Inc		 -
-%		 0.63 - 17.86 0.52 0.69 1.41 9.56
GRIN
Grown Rogue International Inc		 0.03
5.32%		 0.49 23.50 - 3.62 4.10 3.13 11.19

Profile*

Ovation Science Inc

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness solutions under the Invibe MD name; anti-aging products and skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.

1166 Alberni Street, Vancouver, BC, Canada, V6E 3Z3

604 982 5700

https://ovationscience.com

Name Title Year Born
Mr. Terry H. Howlett President, CEO & Director 1948
Ms. Doreen McMorran CFO, VP, COO & Director 1962
Ms. Doreen McMorran CFO, VP, COO & Director 1963

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…